Filing Details
- Accession Number:
- 0000899243-16-033400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-14 19:43:04
- Reporting Period:
- 2016-11-10
- Filing Date:
- 2016-11-14
- Accepted Time:
- 2016-11-14 19:43:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286199 | K Joseph Belanoff | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-10 | 300,000 | $1.50 | 2,464,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-10 | 300,000 | $8.90 | 2,164,195 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-11-11 | 200,000 | $1.50 | 2,364,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-11 | 200,000 | $9.10 | 2,164,195 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-11-10 | 300,000 | $0.00 | 300,000 | $1.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-11-11 | 200,000 | $0.00 | 200,000 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2017-04-16 | No | 4 | M | Direct | |
| 0 | 2017-04-16 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.86 to $9.039 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.91 to $9.36 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
- Fully exercisable.
Billionaire Hedge Funds
